In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker, Chief Operating Officer Luis T. Gutierrez, Jr., and Chief Commercial Officer Jennifer Butler. Solaxa is a pioneering biotech company with a mission to revolutionize the treatment of cerebellar ataxias and acute nerve injuries caused by trauma and chemotherapy.
Discover the compelling story behind Solaxa’s choice to establish its roots in Montgomery County and how the BioHealth Capital Region has played a crucial role in its growth. Learn how Solaxa’s team was assembled, including the inspiring success stories of Luis and Jennifer, both part of the BioHealth Innovation and Montgomery County Maryland’s Executive in Residence program.
Hear how Solaxa is making a difference in the world of neurology with SLX-001, a drug showing immense promise in treating cerebellar ataxias. Dive into their innovative approach, including the development of their treatment for cerebellar ataxias.
Additionally, discover how Solaxa’s pioneering efforts in this field provide hope for healing. Join us for an enlightening discussion on the future of neurology, innovative treatments, and the remarkable journey of Solaxa.
CEO & Founder Christian Walker has focused his last twenty years pursuing the commercialization of nerve injury solutions. Christian’s fundraising experience spans raising money for start-ups, being a start-up venture capitalist, and securing significant non-dilutive financing through grants. At Christian’s prior start-ups, Christian was directly responsible for securing $11M in venture financing. While at Toucan Capital, he served as Principal of a $140 million venture capital fund focused on early-stage investments in stem cells and regenerative medicine. At Johns Hopkins and Walter Reed, he helped secure $22.5M in non-dilutive grants.
Luis T. Gutierrez, Jr. serves as Chief Operating Officer of Solaxa while also serving as an Executive in Residence with BioHealth Innovation. In both roles, he leverages his 25+ years of expertise in helping novel medical technologies with scientific and clinical promise transition to becoming successful commercial enterprises. He previously served in executive roles with Veranex, Theralink Technologies, Aptiv Solutions, and Covance.
Chief Commercial Officer Jennifer Butler has 25 years of broad biotechnology industry experience. Her commercial roles at MedImmune, AstraZeneca, and Innate have equipped her with a deep understanding of commercial execution at large and emerging biopharma. Notably, Jen launched Innate’s first commercial product in a rare oncology population. Jennifer also is also serving as an Executive in Residence with BioHealth Innovation.
Paul Rennie, OBE and Professor Jason Snape (EP.92)
Jeff Boyle, Ellume USA (EP.91)
Howard Carolan, CEO of CoapTech, and Neil Davis, Program Director at University of Maryland Baltimore (UMB) (EP.90)
Murat Kalayoglu, MD, PhD - Cartesian Therapeutics (EP.89)
Dr. Laurie E. Locascio, University of Maryland (EP.88)
Julie Lenzer, University of Maryland (EP.87)
Dr. Anne Khademian, Universities at Shady Grove (USG)
Eric Richman, Gain Therapeutics (EP.85)
Marina Massingham, Aifred Health, and Laurent Waessa, Québec Government Office (EP.84)
Dr. Dipanjan Pan and Phil Robilotto, University of Maryland (EP.83)
Conley Jones, Alexandria Venture Investments (EP.82)
John Mumm, Deka BioSciences (EP.81)
Troy A LeMaile-Stovall, TEDCO (EP.80)
Brett Malone, Virginia Tech Research Center (EP.79)
New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative (EP.78)
Ron Piervincenzi, Ph.D., USP (EP.77)
Chris Mathia, Innara Health, and Keith Molzer, Flyover Capital (EP.76)
Dr. James Crowe Jr. MD, Vanderbilt Vaccine Center (EP.75)
Stu Solomon, Connected DMV (EP.74)
Dr. Carol Nacy, Sequella (EP.73)
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
The Ramsey Show
Planet Money